Oslo, February 29, 2024 -Observe Medical ASA (the "Company" or "Observe
Medical") announces today that Rune Nystad has decided to step down from his
role as Chief Executive Officer ("CEO") with immediate effect to embrace new
challenges within the Company. Jørgen Mann, the current Chief Commercial Officer
("CCO"), will step in as the interim CEO.

Mr. Mann's leadership abilities and deep understanding of the Company's
operations make him well-qualified to oversee the Company's strategy and day-to
-day management during this period. Mr. Nystad will transition into the role as
Chief Development Officer ("CDO") of the Company, where his extensive experience
in product development will be pivotal in driving Observe Medical's strategic
and commercial efforts forward.

The Company's board would like to express its gratitude to Mr. Nystad for his
dedicated service as CEO and looks forward to his continued contributions in the
new role. The board is also confident that Mr. Mann will steer Observe Medical
with the same commitment to excellence as he has proven in his role as CCO.

Further information regarding these organizational changes will be provided as
it becomes available. We are committed to maintaining transparency with our
stakeholders throughout this process.

For further information, please contact:

Jørgen Mann, Interim CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Terje Bakken, Chairman Observe Medical
Mobile: +47 934 33321
E-mail: tb@reitenco.no

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care,
in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik,
Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In
addition, Observe Medical has a direct sale organization in the Nordics and a
distributor network internationally.

Further information is available atwww.observemedical.com.